Healthscope reportedly plans to meet with its key investors before deciding on the takeover offer, according to the report. Analysts at UBS have suggested the private equity consortium might pay more for the company if it were to spin off its pathology assets and break the company into three divisions: hospitals, pathology and property, according to the report.
Healthscope, based in Melbourne, operates 43 hospitals, owns 45 medical clinics, and offers pathology services in Australia, New Zealand and Southeast Asia.
Read The Australian‘s report on Healthscope’s takeover bid by TPG and the Carlyle Group.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
